Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.605
+0.035 (0.98%)
At close: Mar 19, 2026, 4:00 PM EDT
3.610
+0.005 (0.14%)
After-hours: Mar 19, 2026, 4:10 PM EDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of $143.49 million as of March 19, 2026. Its market cap has increased by 66.27% in one year.
Market Cap
143.49M
Enterprise Value
7.47M
1-Year Change
66.27%
Ranking
Category
Stock Price
$3.61
Market Cap Chart
Since May 31, 2007, Oramed Pharmaceuticals's market cap has increased from $29.90M to $143.49M, an increase of 379.89%. That is a compound annual growth rate of 8.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 142.10M | 25.31% |
| Dec 31, 2025 | 113.40M | 16.19% |
| Dec 31, 2024 | 97.60M | 4.72% |
| Dec 29, 2023 | 93.20M | -80.20% |
| Dec 30, 2022 | 470.60M | -13.48% |
| Dec 31, 2021 | 543.90M | 441.73% |
| Dec 31, 2020 | 100.40M | 12.05% |
| Dec 31, 2019 | 89.60M | 71.98% |
| Dec 31, 2018 | 52.10M | -59.55% |
| Dec 29, 2017 | 128.80M | 58.62% |
| Dec 30, 2016 | 81.20M | -18.15% |
| Dec 31, 2015 | 99.20M | 115.18% |
| Dec 31, 2014 | 46.10M | -62.40% |
| Dec 31, 2013 | 122.60M | 330.18% |
| Dec 31, 2012 | 28.50M | 45.41% |
| Dec 30, 2011 | 19.60M | 11.36% |
| Dec 31, 2010 | 17.60M | -31.52% |
| Dec 31, 2009 | 25.70M | 16.82% |
| Dec 31, 2008 | 22.00M | 83.33% |
| Dec 31, 2007 | 12.00M | -59.87% |
| May 31, 2007 | 29.90M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 150.03M |
| Vaxart | 149.15M |
| Unicycive Therapeutics | 145.28M |
| Agenus | 144.38M |
| Artiva Biotherapeutics | 143.36M |
| vTv Therapeutics | 142.97M |
| Spero Therapeutics | 138.59M |
| Inhibikase Therapeutics | 137.57M |